SERPINB2 and liver cancer: GSEA revealed a strong relationship between the significantly enhanced expression of SERPINB2 and metastatic progression or recurrence in multiple cancer types, including breast (Figure 3D), colorectal (Figure 3E) and liver cancers (Figure 3F).